672P Phase I/II trial of RVU120 (SEL120), CDK8/CDK19 inhibitor in patients with relapsed/refractory metastatic or advanced solid tumors

Autor: Dziadziuszko, R., Lugowska, I., Garralda, E., Rojas Laimito, K.I., Rzymski, T., Dudziak, R., Littlewood, P., Nogai, H., Boni, V., Fuentes Antras, J., Alonso, G., Saavedra Santa Gadea, O., Kuklík, R.
Zdroj: In Annals of Oncology October 2023 34 Supplement 2:S472-S472
Databáze: ScienceDirect